March 3, 2025 – BioMatrix Infusion Pharmacy, a leading provider in ambulatory and home infusion services, has announced the acquisition of MyLyfe Health. MyLyfe Health specializes in specialty pharmacy, home infusion, and infusion suite services for patients with chronic, lifelong medical conditions.
This strategic acquisition strengthens BioMatrix’s position in the infusion pharmacy market, expanding its capabilities to better serve patients with complex and chronic conditions. By integrating MyLyfe’s expertise, resources, and geographic footprint, BioMatrix will enhance access to infused medications through home infusion and ambulatory infusion center capabilities, build upon existing patient support services, and drive continued innovation in pharmaceutical care.
“We are thrilled to welcome MyLyfe Health to the BioMatrix family,” said Ted Kramm, BioMatrix Chief Executive Officer. “This acquisition aligns with our mission to provide high-quality, patient-centered care while expanding our footprint in the infusion pharmacy sector. Together, we will offer enhanced services, improved medication access, and superior outcomes for our patients.”
MyLyfe is renowned for its unwavering commitment to putting patients first, prioritizing their well-being, and enhancing their quality of life. This dedication is driven by the clinical expertise of its pharmacy staff, ensuring appropriate therapy, the safe administration of infused medications, and compassionate, empathetic care. The integration of both organizations will create a seamless transition for patients, prescribers, and partners, reinforcing a shared mission of excellence in patient-centered care.
“The combination of our two companies will allow us to further elevate infusion pharmacy services,” said Mark Zatyrka, Founder and CEO, MyLyfe. “We are excited about the opportunities ahead and are confident that this partnership will provide greater value to our patients and healthcare providers.”
The acquisition underscores BioMatrix’s commitment to expanding its specialty infusion pharmacy services and reinforces its dedication to improving patient outcomes. Additional information on BioMatrix and MyLyfe can be found at www.biomatrixsprx.com and https://mylyfehealth.com.
About BioMatrix Specialty Pharmacy
BioMatrix Specialty Pharmacy, an Inc. 5000 company, offers comprehensive, nationwide specialty infusion pharmacy services and digital health technology solutions for patients with chronic, difficult to treat conditions. Our commitment to every patient is to provide individualized pharmacy services, timely access to care, and focused education and support. We offer a tailored approach for a wide range of therapeutic categories, improving health and empowering patients to experience a higher quality of life.
The M&A market for healthcare companies continues to build on STRATEGIC opportunities and a fragmented market. Consolidations along with unprecedented demand are driving scale across the continuum of care. The strategic corporate buyers and private equity investors remain committed to acquiring strong businesses that are well prepared for a transaction. Across the continuum of care, these buyers and investors are looking for well established, profitable businesses and offering prime valuations and options for management.
Do you know the current market value of your business? We do! We are here to help you plan, prepare, explore and succeed in executing your strategic options.
Contact Paragon Ventures for more information.
800-719-1555
